Zacks.com on MSN1d
Zymeworks (ZYME) Soars 5.4%: Is Further Upside Left in the Stock?Zymeworks (ZYME) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
On April 5, 2023, Stefani A. Wolff notified Nurix Therapeutics (NRIX) of her decision to resign from her position as Chief ...
Zacks Investment Research on MSN2d
Xilio Therapeutics, Inc. (XLO) Reports Q4 Loss, Lags Revenue EstimatesXilio Therapeutics, Inc. (XLO) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.64 per share a year ago. These ...
After hours: March 10 at 4:32:22 PM EDT Loading Chart for NRIX ...
Baker Brothers' 13F portfolio value decreased from $9.65B to $9.36B. Check out the portfolio's top holdings and notable stake ...
After hours: March 3 at 4:38:52 p.m. EST ...
After hours: March 11 at 6:08:44 p.m. EDT Loading Chart for ITOS ...
After hours: 28 February at 7:58:04 pm GMT-5 ...
As of 11:46:20 am GMT-4. Market open. Loading Chart for HRMY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback